Neuphoria Therapeutics, Inc. (NEUP) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Neuphoria Therapeutics, Inc. - NEUP emitenti grafik logotipi

Klinik sinovlarning rivojlanishi mablag'larning doimiy ravishda kirib kelishini talab qiladi, shunga qaramay, Neuphoria Therapeutics Inc. (NEUP) kompaniyasining joriy rezervlari yetarli darajada qolmoqda. Uzoq muddatli qarzning kapitalga nisbati 0.00 eng so'nggi ko'rsatkichni ifodalovchi qarz profilini namoyish etadi. Rahbariyat strategik sherikliklarni izlab, xavotirga qarshi dori vositalarini faol ravishda targ'ib qilmoqda. Psixiatrik kasalliklar uchun kichik molekulalarning yaratilishi dori vositalarining takroriy sotuvlari uchun yuqori inersiyani ta'minlaydi.

bionomics.com.au (NEUP): Uzoq muddatli qarzning o'z kapitaliga nisbati 25.12.2024dan 01.11.2026gacha

Neuphoria Therapeutics Inc. kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Neuphoria|NEUP - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Neuphoria Therapeutics Inc.|NEUP - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Neuphoria Therapeutics|NEUP - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati bionomics.com.au|NEUP - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Neuphoria Therapeutics Inc.|NEUP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Neuphoria|NEUP - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Neuphoria Therapeutics Inc.|NEUP - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Neuphoria Therapeutics|Kritik likvidlik koeffitsiyenti bionomics.com.au
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
NEUP - Sof foyda
Kompaniyaning jamlanma tahlili:NEUP (bionomics.com.au)
bionomics.com.au original mahsuloti

Molekulalarni skrining qilish uchun laboratoriya robototexnikasini joriy etish avtomatlashtirishga sezilarli kapital xarajatlarni talab qiladi. Ushbu koeffitsient bir yildan ortiq muddatli majburiyatlarni kompaniyaning o'z kapitaliga nisbatda bog'laydi. Ushbu metrikaning o'sishi R&D (tadqiqot va ishlanmalar)ni moliyalashtirish uchun kredit yuklamasining ortayotganidan dalolat beradi. Investorlar uchun qarz kapitali va moliyaviy barqarorlik o'rtasidagi muvozanatni baholash juda muhimdir. Uzoq muddatli qarzning kapitalga nisbati grafigini tahlil qilish orqali Neuphoria Therapeutics Inc. (NEUP) kompaniyasining qarz yuklamasi darajasini aniqlash mumkin.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HRMY (harmonybiosciences.com)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Praxis Corp PRAX|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CBLL|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati Omeros Corp. OMER|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc. (NGNE)|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Neumora (NMRA)|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|TVGN - Uzoq muddatli qarzning kapitalga nisbati|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati IKT|SAVA (Cassava Sciences Inc) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRVO (CervoMed, Inc.)|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Clene (CLNN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PepGen Inc|jupiterneurosciences.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|ANVS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Firefly Neuro AIFF|KLTO: Uzoq muddatli qarzning o'z kapitaliga nisbati|NeuroSense Therapeutics - Uzoq muddatli kreditlarning kapitalga nisbati|RVPH: Uzoq muddatli qarzning kapitalga nisbati|MTVA - Uzoq muddatli qarzdorlikning kapitalga nisbati|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies Inc. (HSDT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. (PASG)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ADXN|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cyclerion Therapeutics CYCN|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi KTTA|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics Inc. (ATXI)|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (Brainstorm Cell Therapeutics, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Cara Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|MRNS (Marinus) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp (NKGN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|sagerx.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Trevena Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati